Skip to main content

Advertisement

ADVERTISEMENT

Exclusives

News
02/26/2024
A retrospective study assessing the impact of the Swift Skin & Wound system in pressure injury care has been published. The study in skilled nursing facilities showed improvements in patient care and quality of life and significant savings in...
A retrospective study assessing the impact of the Swift Skin & Wound system in pressure injury care has been published. The study in skilled nursing facilities showed improvements in patient care and quality of life and significant savings in...
A retrospective study assessing...
02/26/2024
Wound Care
News
02/26/2024
Merakris announced preliminary data from the first of a two-part Phase II multi-center, 12-patient clinical study for Dermacyte amniotic liquid for VSU treatment reported an 84% average reduction in ulcer surface area for 9 patients. Part 2...
Merakris announced preliminary data from the first of a two-part Phase II multi-center, 12-patient clinical study for Dermacyte amniotic liquid for VSU treatment reported an 84% average reduction in ulcer surface area for 9 patients. Part 2...
Merakris announced preliminary...
02/26/2024
Wound Care
News
02/26/2024
3M announced filing a Form 10 registration statement with the US SEC for the spin-off of Solventum as an independent health care company. Solventum, which had sales of $8.2B in 2023, is anticipated to spin off from 3M on Apr 1, 2024, subject...
3M announced filing a Form 10 registration statement with the US SEC for the spin-off of Solventum as an independent health care company. Solventum, which had sales of $8.2B in 2023, is anticipated to spin off from 3M on Apr 1, 2024, subject...
3M announced filing a Form 10...
02/26/2024
Wound Care
News
02/26/2024
Rion announced the initiation of a 40-patient Phase 2A study to evaluate its Purified Exosome Products (PEP) in the treatment of DFUs.  A positive outcome of the pivotal study will be followed by the submission of a Biologics Application...
Rion announced the initiation of a 40-patient Phase 2A study to evaluate its Purified Exosome Products (PEP) in the treatment of DFUs.  A positive outcome of the pivotal study will be followed by the submission of a Biologics Application...
Rion announced the initiation of...
02/26/2024
Wound Care
News
02/26/2024
A narrative review evaluated the long-term management strategies for lymphedema and CVI and highlighted a nonpneumatic compression device (NPCD) designed for the management of lymphedema and CVI. The NPCD demonstrated improved efficacy,...
A narrative review evaluated the long-term management strategies for lymphedema and CVI and highlighted a nonpneumatic compression device (NPCD) designed for the management of lymphedema and CVI. The NPCD demonstrated improved efficacy,...
A narrative review evaluated the...
02/26/2024
Wound Care
News
02/26/2024
The first clinical evaluation of Aurase was published. The 41-patient trial, in which the product was applied 3 times weekly for 4 weeks, indicated that the product was well tolerated with no systemic absorption. International Wound Journal
The first clinical evaluation of Aurase was published. The 41-patient trial, in which the product was applied 3 times weekly for 4 weeks, indicated that the product was well tolerated with no systemic absorption. International Wound Journal
The first clinical evaluation of...
02/26/2024
Wound Care
News
02/20/2024
A study evaluated the efficacy and safety of platelet-rich plasma (PRP) in comparison to conventional therapy in the treatment of venous ulcers. The study found PRP significantly enhanced complete ulcer healing, exhibiting an odds ratio of 5....
A study evaluated the efficacy and safety of platelet-rich plasma (PRP) in comparison to conventional therapy in the treatment of venous ulcers. The study found PRP significantly enhanced complete ulcer healing, exhibiting an odds ratio of 5....
A study evaluated the efficacy...
02/20/2024
Wound Care
News
02/20/2024
A 50-patient RCT will examine efficacy and safety of a bio-absorbable antibiotic delivery in calcium sulphate granules for treatment of osteomyelitis in patients with diabetic foot. Primary outcome is percent of recurrence, new cases or...
A 50-patient RCT will examine efficacy and safety of a bio-absorbable antibiotic delivery in calcium sulphate granules for treatment of osteomyelitis in patients with diabetic foot. Primary outcome is percent of recurrence, new cases or...
A 50-patient RCT will examine...
02/20/2024
Wound Care
News
02/20/2024
Kerecis, part of Coloplast, announces the availability of Shield Standard, a new product that combines a fish-skin graft and silicone backing for efficient treatment of acute and chronic wounds.
Kerecis, part of Coloplast, announces the availability of Shield Standard, a new product that combines a fish-skin graft and silicone backing for efficient treatment of acute and chronic wounds.
Kerecis, part of Coloplast,...
02/20/2024
Wound Care
News
02/20/2024
A Swedish registry-based study investigated the association between given self-care advice and healing time in patients with VLUs while controlling for demographic and ulcer-related factors. The study found no association between shorter...
A Swedish registry-based study investigated the association between given self-care advice and healing time in patients with VLUs while controlling for demographic and ulcer-related factors. The study found no association between shorter...
A Swedish registry-based study...
02/20/2024
Wound Care

Advertisement

Advertisement

Advertisement